Management of Post-Stroke Pain

Treatment Algorithm

The International Journal of Stroke recommends tramadol as a third-line treatment option for central post-stroke pain that has not responded to first-line anticonvulsants or second-line antidepressants 1
The American Heart Association suggests starting with anticonvulsants (gabapentin or pregabalin) as the initial pharmacological approach for central post-stroke pain 1
Amitriptyline and lamotrigine are also reasonable first-line options, with amitriptyline 75 mg at bedtime showing effectiveness in lowering daily pain ratings 2, 3
The Canadian Stroke Best Practice guidelines recommend using tricyclic antidepressants (amitriptyline) or SNRIs (particularly duloxetine) if anticonvulsants fail 1

Tramadol carries a higher risk of seizures, especially at doses exceeding 400 mg daily 4
The Canadian guidelines specifically warn about significant risk of physical dependency with opioids including tramadol 1
Avoid combining tramadol with CNS depressants (benzodiazepines, antipsychotics) due to risk of respiratory depression and excessive sedation 5
There is a risk of serotonin syndrome when combining tramadol with SSRIs, TCAs, or MAOIs 4

Use standardized pain measurements, such as visual analog scales, pain diaries, or pain questionnaires to assess treatment response 2, 3
Monitor for adverse effects, including nausea, dizziness, confusion, which are more common with tramadol than other opioids 4